Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil Treatment for Traumatic Vascular Injury in Athletes
NCT03598140Phase 2Terminated
- Sponsor
- UT Southwestern Medical Center
- Start
- Jul 2018
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ASP-001 in traumatic brain injury (TBI), sponsored by UT Southwestern Medical Center. Started Jul 2018; status: terminated.
02
Drugs
ASP-001
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT03598140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03598140.